Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
160K
-
Shares change
-
-99.4K
-
Total reported value, excl. options
-
$7.95M
-
Value change
-
-$4.96M
-
Number of sells
-
-5
-
Price
-
$49.73
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q4 2023
7 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q4 2023.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 160K shares
of 1.23B outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include Dodge & Cox (78.3M shares), FMR LLC (20.4M shares), Fisher Asset Management, LLC (14.3M shares), Boston Partners (13M shares), BlackRock Inc. (10.3M shares), BANK OF AMERICA CORP /DE/ (10.2M shares), MORGAN STANLEY (7.87M shares), Invesco Ltd. (6.92M shares), Bank of New York Mellon Corp (6.2M shares), and Nuveen Asset Management, LLC (4.5M shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.